TianYu Bio-Technology Co EBIT per Employee
The EBIT per Employee of TianYu Bio-Technology Co (603717.SS) as of Oct 11, 2026 is -219,737.60 CNY. In the previous year, EBIT per Employee was -201,055.87 CNY — a change of 9.29% (lower).
Get this data via API
Financial Data API
EBIT per Employee
-219,737.60CNY
YoY
9.29%
Last updated:
The TianYu Bio-Technology Co EBIT per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Employee | YoY |
|---|---|---|
| -219,737.60CNY | +9.29% | |
| -201,055.87CNY | -83.62% | |
| -1.23 MCNY | +92.42% | |
| -637,791.66CNY | +18.22% | |
| -539,506.48CNY | +43.87% | |
| -374,985.94CNY | -341.60% | |
| 155,212.38CNY | -53.29% | |
| 332,285.00CNY | +2.61% | |
| 323,835.54CNY | -11.89% | |
| 367,547.89CNY | +39.84% | |
| 262,842.74CNY | +7.43% | |
| 244,653.72CNY | — |
TianYu Bio-Technology Co Stock analysis
Frequently Asked Questions about TianYu Bio-Technology Co stock
EBIT per Employee of TianYu Bio-Technology Co is -219,737.60 CNY in 2025.
EBIT per Employee of TianYu Bio-Technology Co changed from -201,055.87 CNY to -219,737.60 CNY, representing a 9.29% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Employee TianYu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.
EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's TianYu Bio-Technology Co historically and in real time.
Workforce — TianYu Bio-Technology Co
All Key Metrics — TianYu Bio-Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth